PIK3CA and cancer: To examine the potential synergy of these two cancer-associated genes in the transformation process, we combined the activated form of PIK3CA harboring the H1047R mutation with a biallelic knock-out of KMT2D in the non-tumorigenic mammary epithelial cell line MCF10A [16], and studied phenotypic consequences of the two genetic alterations when introduced in isolation or combined.